Yunnan Baiyao Group Co.,Ltd (SHE:000538)
55.92
-0.08 (-0.14%)
Aug 14, 2025, 2:45 PM CST
Arcadium Lithium Revenue
Yunnan Baiyao Group Co.,Ltd had revenue of 10.84B CNY in the quarter ending March 31, 2025, with 0.62% growth. This brings the company's revenue in the last twelve months to 40.10B, up 1.85% year-over-year. In the year 2024, Yunnan Baiyao Group Co.,Ltd had annual revenue of 40.03B with 2.36% growth.
Revenue (ttm)
40.10B
Revenue Growth
+1.85%
P/S Ratio
2.49
Revenue / Employee
4.32M
Employees
9,277
Market Cap
99.92B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 40.03B | 922.01M | 2.36% |
Dec 31, 2023 | 39.11B | 2.62B | 7.19% |
Jan 1, 2023 | 36.49B | 114.45M | 0.31% |
Jan 1, 2022 | 36.37B | 3.63B | 11.09% |
Dec 31, 2020 | 32.74B | 3.08B | 10.38% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jan 1, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
WuXi AppTec | 41.48B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
Aier Eye Hospital Group | 21.81B |
Sichuan Biokin Pharmaceutical | 5.82B |
Shanghai United Imaging Healthcare | 10.43B |
Huadong Medicine | 42.23B |